POST-MARKETING DRUG SURVEILLANCE - COMPARISON OF METHODS

被引:0
|
作者
REMINGTON, RD
机构
来源
AMERICAN JOURNAL OF PHARMACY | 1978年 / 150卷 / 03期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
下载
收藏
页码:72 / 80
页数:9
相关论文
共 50 条
  • [31] Post-Marketing Surveillance of Prescription Drug Safety: Past, Present, and Future
    Chen, Brian K.
    Yang, Y. Tony
    JOURNAL OF LEGAL MEDICINE, 2013, 34 (02) : 193 - 213
  • [32] Hemangiol in infantile haemangioma: A paediatric post-marketing surveillance drug study
    Socchi, Floriane
    Bigorre, Michele
    Normandin, Marion
    Captier, Guillaume
    Bessis, Didier
    Mondain, Michel
    Blanchet, Catherine
    Akkari, Mohamed
    Amedro, Pascal
    Gavotto, Arthur
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 1970 - 1980
  • [33] Overview and Comparison of Post-Marketing Drug Safety Surveillance in Developing Countries and Other Well Developed Regions
    Vaidya, Sampada S.
    Guo, Jeff J.
    Heaton, Pamela C.
    Steinbuck, Michael
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S178 - S178
  • [34] Post-marketing surveillance of escitalopram in depressed outpatients
    Möller, HJ
    Lotze, K
    Lange, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S428 - S428
  • [35] Challenges and perspectives in surveillance of post-marketing/use
    Fontenele Martins, Mary Anne
    Coelho Penna Teixeira, Ana Paula
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2019, 7 (04): : 3 - 9
  • [36] A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance
    Shubhadeep Chakraborty
    Ram Tiwari
    Therapeutic Innovation & Regulatory Science, 2025, 59 (1) : 89 - 101
  • [37] Post-marketing surveillance of escitalopram in depressed outpatients
    Moeller, H.-J.
    Lotze, K.
    Langer, S.
    Montgomery, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S259 - S259
  • [38] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [40] Distributed, collaborative intelligent agents for proactive post-marketing drug safety surveillance
    Ji, Yanqing
    Ying, Hao
    Farber, Margo S.
    Yen, John
    Dews, Peter
    Miller, Richard E.
    Massanari, R. Michael
    NAFIPS 2007 - 2007 ANNUAL MEETING OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY, 2007, : 158 - +